Collegium Pharmaceutical, Inc. Operating Income
Collegium Pharmaceutical, Inc. (COLL) reported Operating Income of $3.70 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-06
- Collegium Pharmaceutical, Inc. operating income (loss) for the quarter ending 2026-06-30 was $3.70M, a 89.47% decline year-over-year.
- Collegium Pharmaceutical, Inc. operating income (loss) for the quarter ending 2026-03-31 was $30.90M, a 42.46% increase year-over-year.
- Collegium Pharmaceutical, Inc. operating income (loss) for the quarter ending 2025-12-31 was $60.76M, a 59.42% increase year-over-year.
- Collegium Pharmaceutical, Inc. operating income (loss) for the quarter ending 2025-09-30 was $62.09M, a 78.21% increase year-over-year.
- Collegium Pharmaceutical, Inc. operating income (loss) for fiscal 2025 was $179.64M, a 5.73% increase from fiscal 2024.
- Collegium Pharmaceutical, Inc. operating income (loss) for fiscal 2024 was $169.90M, a 1.76% increase from fiscal 2023.
- Collegium Pharmaceutical, Inc. operating income (loss) for fiscal 2023 was $166.96M, a 401.10% increase from fiscal 2022.
- Collegium Pharmaceutical, Inc. operating income (loss) for fiscal 2022 was $33.32M, a 89.01% increase from fiscal 2021.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $3.70M 10-Q · filed 2026-08-06 | $34.59M 10-Q · filed 2026-08-06 | $95.35M derived: sum of 3 quarters · filed 2026-08-06 | $157.44M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $30.90M 10-Q · filed 2026-05-07 | $91.65M derived: sum of 2 quarters · filed 2026-05-07 | $153.74M derived: sum of 3 quarters · filed 2026-05-07 | $188.84M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $60.76M 10-K · filed 2026-02-26 | $122.84M derived: sum of 2 quarters · filed 2026-02-26 | $157.95M derived: sum of 3 quarters · filed 2026-08-06 | $179.64M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $62.09M 10-K · filed 2026-02-26 | $97.19M derived: sum of 2 quarters · filed 2026-08-06 | $118.88M 10-Q · filed 2025-11-06 | $156.99M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $35.10M 10-Q · filed 2026-08-06 | $56.79M 10-Q · filed 2026-08-06 | $94.90M derived: sum of 3 quarters · filed 2026-08-06 | $129.74M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $21.69M 10-Q · filed 2026-05-07 | $59.80M derived: sum of 2 quarters · filed 2026-05-07 | $94.64M derived: sum of 3 quarters · filed 2026-05-07 | $142.11M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $38.11M 10-K · filed 2026-02-26 | $72.95M derived: sum of 2 quarters · filed 2026-02-26 | $120.42M derived: sum of 3 quarters · filed 2026-02-26 | $169.90M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $34.84M 10-K · filed 2026-02-26 | $82.31M derived: sum of 2 quarters · filed 2026-02-26 | $131.78M 10-Q · filed 2025-11-06 | $193.47M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $47.47M 10-K · filed 2026-02-26 | $96.94M 10-Q · filed 2025-08-07 | $158.63M derived: sum of 3 quarters · filed 2026-02-26 | $203.65M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $49.47M 10-K · filed 2026-02-26 | $111.16M derived: sum of 2 quarters · filed 2026-02-26 | $156.18M derived: sum of 3 quarters · filed 2026-02-26 | $191.81M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | $61.69M 10-K · filed 2025-02-27 | $106.70M derived: sum of 2 quarters · filed 2025-02-27 | $142.33M derived: sum of 3 quarters · filed 2025-02-27 | $166.96M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $45.01M 10-K · filed 2025-02-27 | $80.65M derived: sum of 2 quarters · filed 2025-02-27 | $105.27M 10-Q · filed 2024-11-07 | $117.03M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | $35.63M 10-K · filed 2025-02-27 | $60.26M 10-Q · filed 2024-08-08 | $72.02M derived: sum of 3 quarters · filed 2025-02-27 | $92.48M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | $24.63M 10-K · filed 2025-02-27 | $36.38M derived: sum of 2 quarters · filed 2025-02-27 | $56.85M derived: sum of 3 quarters · filed 2025-02-27 | $67.96M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | $11.76M 10-K · filed 2024-02-22 | $32.22M derived: sum of 2 quarters · filed 2024-02-22 | $43.33M derived: sum of 3 quarters · filed 2024-02-22 | $33.32M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $20.47M 10-K · filed 2024-02-22 | $31.58M derived: sum of 2 quarters · filed 2024-02-22 | $21.56M 10-Q · filed 2023-11-07 | -$12.56M derived: sum of 4 quarters · filed 2024-02-22 | |
| 2022-06-30 | $11.11M 10-K · filed 2024-02-22 | $1.09M 10-Q · filed 2023-08-03 | -$33.03M derived: sum of 3 quarters · filed 2024-02-22 | -$18.88M derived: sum of 4 quarters · filed 2024-02-22 | |
| 2022-03-31 | -$10.02M 10-K · filed 2024-02-22 | -$44.14M derived: sum of 2 quarters · filed 2024-02-22 | -$29.99M derived: sum of 3 quarters · filed 2024-02-22 | -$13.58M derived: sum of 4 quarters · filed 2024-02-22 | |
| 2021-12-31 | -$34.12M 10-K · filed 2023-02-23 | -$19.97M derived: sum of 2 quarters · filed 2023-02-23 | -$3.56M derived: sum of 3 quarters · filed 2023-02-23 | $17.63M 10-K · filed 2024-02-22 | |
| 2021-09-30 | $14.15M 10-K · filed 2023-02-23 | $30.56M derived: sum of 2 quarters · filed 2023-02-23 | $51.75M 10-Q · filed 2022-11-03 | $66.75M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-06-30 | $16.41M 10-K · filed 2023-02-23 | $37.60M 10-Q · filed 2022-08-04 | $52.60M derived: sum of 3 quarters · filed 2023-02-23 | $72.22M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-03-31 | $21.19M 10-K · filed 2023-02-23 | $36.19M derived: sum of 2 quarters · filed 2023-02-23 | $55.81M derived: sum of 3 quarters · filed 2023-02-23 | $72.36M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2020-12-31 | $15.00M 10-K · filed 2022-02-24 | $34.62M derived: sum of 2 quarters · filed 2022-02-24 | $51.17M derived: sum of 3 quarters · filed 2022-02-24 | $56.23M 10-K · filed 2023-02-23 | |
| 2020-09-30 | $19.63M 10-K · filed 2022-02-24 | $36.17M derived: sum of 2 quarters · filed 2022-02-24 | $41.24M 10-Q · filed 2021-11-04 | $38.86M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-06-30 | $16.55M 10-K · filed 2022-02-24 | $21.61M 10-Q · filed 2021-08-05 | $19.24M derived: sum of 3 quarters · filed 2022-02-24 | $12.86M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-03-31 | $5.06M 10-K · filed 2022-02-24 | $2.69M derived: sum of 2 quarters · filed 2022-02-24 | -$3.69M derived: sum of 3 quarters · filed 2022-02-24 | -$8.70M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2019-12-31 | -$2.37M 10-K · filed 2021-02-25 | -$8.75M derived: sum of 2 quarters · filed 2021-02-25 | -$13.76M derived: sum of 3 quarters · filed 2021-02-25 | -$23.75M 10-K · filed 2022-02-24 | |
| 2019-09-30 | -$6.38M 10-K · filed 2021-02-25 | -$11.38M derived: sum of 2 quarters · filed 2021-02-25 | -$21.38M 10-Q · filed 2020-11-05 | -$10.37M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-06-30 | -$5.01M 10-K · filed 2021-02-25 | -$15.00M 10-Q · filed 2020-08-05 | -$4.00M derived: sum of 3 quarters · filed 2021-02-25 | -$15.19M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-03-31 | -$9.99M 10-K · filed 2021-02-25 | $1.01M derived: sum of 2 quarters · filed 2021-02-25 | -$10.18M derived: sum of 3 quarters · filed 2021-02-25 | -$17.47M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2018-12-31 | $11.00M 10-K · filed 2020-02-27 | -$185.00K derived: sum of 2 quarters · filed 2020-02-27 | -$7.48M derived: sum of 3 quarters · filed 2020-02-27 | -$20.68M 10-K · filed 2021-02-25 | |
| 2018-09-30 | -$11.19M 10-K · filed 2020-02-27 | -$18.48M derived: sum of 2 quarters · filed 2020-02-27 | -$31.69M 10-Q · filed 2019-11-06 | -$49.27M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-06-30 | -$7.29M 10-K · filed 2020-02-27 | -$20.50M 10-Q · filed 2019-08-07 | -$38.08M derived: sum of 3 quarters · filed 2020-02-27 | -$51.51M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-03-31 | -$13.21M 10-K · filed 2020-02-27 | -$30.79M derived: sum of 2 quarters · filed 2020-02-27 | -$44.22M derived: sum of 3 quarters · filed 2020-02-27 | -$65.48M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2017-12-31 | -$17.58M 10-K · filed 2019-02-27 | -$31.01M derived: sum of 2 quarters · filed 2019-02-27 | -$52.27M derived: sum of 3 quarters · filed 2019-02-27 | -$75.45M 10-K · filed 2020-02-27 | |
| 2017-09-30 | -$13.43M 10-K · filed 2019-02-27 | -$34.69M derived: sum of 2 quarters · filed 2019-02-27 | -$57.86M 10-Q · filed 2018-11-08 | -$85.44M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-06-30 | -$21.26M 10-K · filed 2019-02-27 | -$44.43M 10-Q · filed 2018-08-08 | -$72.01M derived: sum of 3 quarters · filed 2019-02-27 | -$98.45M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-03-31 | -$23.18M 10-K · filed 2019-02-27 | -$50.76M derived: sum of 2 quarters · filed 2019-02-27 | -$77.20M derived: sum of 3 quarters · filed 2019-02-27 | -$101.67M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2016-12-31 | -$27.58M 10-K · filed 2018-03-07 | -$54.02M derived: sum of 2 quarters · filed 2018-03-07 | -$78.50M derived: sum of 3 quarters · filed 2018-03-07 | -$94.08M 10-K · filed 2019-02-27 | |
| 2016-09-30 | -$26.44M 10-K · filed 2018-03-07 | -$50.92M derived: sum of 2 quarters · filed 2018-03-07 | -$66.50M 10-Q · filed 2017-11-08 | -$75.94M derived: sum of 4 quarters · filed 2018-03-07 | |
| 2016-06-30 | -$24.47M 10-K · filed 2018-03-07 | -$40.06M 10-Q · filed 2017-08-09 | -$49.50M derived: sum of 3 quarters · filed 2018-03-07 | -$58.76M derived: sum of 4 quarters · filed 2018-03-07 | |
| 2016-03-31 | -$15.59M 10-K · filed 2018-03-07 | -$25.02M derived: sum of 2 quarters · filed 2018-03-07 | -$34.29M derived: sum of 3 quarters · filed 2018-03-07 | -$38.86M derived: sum of 4 quarters · filed 2018-03-07 | |
| 2015-12-31 | -$9.44M 10-K · filed 2017-03-10 | -$18.70M derived: sum of 2 quarters · filed 2017-03-10 | -$23.28M derived: sum of 3 quarters · filed 2017-03-10 | -$26.91M 10-K · filed 2018-03-07 | |
| 2015-09-30 | -$9.27M 10-K · filed 2017-03-10 | -$13.84M derived: sum of 2 quarters · filed 2017-03-10 | -$17.47M 10-Q · filed 2016-11-10 | -$20.80M derived: sum of 4 quarters · filed 2017-03-10 | |
| 2015-06-30 | -$4.58M 10-K · filed 2017-03-10 | -$8.21M 10-Q · filed 2016-08-11 | -$11.53M derived: sum of 3 quarters · filed 2017-03-10 | -$18.04M derived: sum of 4 quarters · filed 2017-03-10 | |
| 2015-03-31 | -$3.63M 10-K · filed 2017-03-10 | -$3.63M 10-Q/A · filed 2015-07-17 | -$6.96M derived: sum of 2 quarters · filed 2017-03-10 | -$13.46M derived: sum of 3 quarters · filed 2017-03-10 | -$17.55M derived: sum of 4 quarters · filed 2017-03-10 |
| 2014-12-31 | -$3.33M 10-K · filed 2016-03-18 | -$9.83M derived: sum of 2 quarters · filed 2016-03-18 | -$13.92M derived: sum of 3 quarters · filed 2016-03-18 | -$17.66M 10-K · filed 2017-03-10 | |
| 2014-09-30 | -$6.50M 10-K · filed 2016-03-18 | -$10.59M derived: sum of 2 quarters · filed 2016-03-18 | -$14.34M 10-Q · filed 2015-11-12 | ||
| 2014-06-30 | -$4.09M 10-K · filed 2016-03-18 | -$7.83M 10-Q · filed 2015-08-12 | |||
| 2014-03-31 | -$3.75M 10-K · filed 2016-03-18 | -$3.74M 10-Q/A · filed 2015-07-17 | |||
| 2013-12-31 | -$16.04M 10-K · filed 2016-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |